Drugs used to treat diabetes could be used to reduce pancreatic and prostate tumor growth

July 14, 2015

UCLA scientists have identified a new mechanism that delivers a key substance that fuels the growth of pancreatic and prostate cancer cells, a finding that offers new hope in the fight against two of the deadliest forms of the disease.

Cancer cells require high amounts of the  to survive and grow, and long-standing research has established passive glucose transporters, known as GLUTS, as the primary method the body uses to deliver glucose to tumors. 

Read the full story.